Exclusive Lumere Research: What does the clinical evidence say about brexanolone? Review the Research
Get Started Sign In

Lumere Closes Strategic Growth Capital Funding

Chicago, IL (February 11, 2019) - Lumere, Inc., a leading provider of evidence-based analytics and services to reduce unwarranted and costly clinical variation, announced today the closure of a significant round of funding led by Heritage Group. The additional capital will be used to develop and further expand service offerings that enable evidence-led change at health systems nationwide. read more

Categories